关注
Nobuyuki Okamura
Nobuyuki Okamura
Tohoku Medical and Pharmaceutical University
在 tohoku-mpu.ac.jp 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls
M Maruyama, H Shimada, T Suhara, H Shinotoh, B Ji, J Maeda, ...
Neuron 79 (6), 1094-1108, 2013
8402013
18F-THK523: a novel in vivo tau imaging ligand for Alzheimer’s disease
MT Fodero-Tavoletti, N Okamura, S Furumoto, RS Mulligan, AR Connor, ...
Brain 134 (4), 1089-1100, 2011
4002011
18F-THK5351: a novel PET radiotracer for imaging neurofibrillary pathology in Alzheimer disease
R Harada, N Okamura, S Furumoto, K Furukawa, A Ishiki, N Tomita, ...
Journal of Nuclear Medicine 57 (2), 208-214, 2016
3602016
Monoamine oxidase B inhibitor, selegiline, reduces 18F-THK5351 uptake in the human brain
KP Ng, TA Pascoal, S Mathotaarachchi, J Therriault, MS Kang, M Shin, ...
Alzheimer's research & therapy 9, 1-9, 2017
3372017
Novel 18F-labeled arylquinoline derivatives for noninvasive imaging of tau pathology in Alzheimer disease
N Okamura, S Furumoto, R Harada, T Tago, T Yoshikawa, ...
Journal of Nuclear Medicine 54 (8), 1420-1427, 2013
3352013
2-(2-[2-Dimethylaminothiazol-5-yl] ethenyl)-6-(2-[fluoro] ethoxy) benzoxazole: a novel PET agent for in vivo detection of dense amyloid plaques in Alzheimer's disease patients
Y Kudo, N Okamura, S Furumoto, M Tashiro, K Furukawa, M Maruyama, ...
Journal of Nuclear Medicine 48 (4), 553-561, 2007
3092007
Non-invasive assessment of Alzheimer’s disease neurofibrillary pathology using 18F-THK5105 PET
N Okamura, S Furumoto, MT Fodero-Tavoletti, RS Mulligan, R Harada, ...
Brain 137 (6), 1762-1771, 2014
3052014
Quinoline and benzimidazole derivatives: candidate probes for in vivo imaging of tau pathology in Alzheimer's disease
N Okamura, T Suemoto, S Furumoto, M Suzuki, H Shimadzu, H Akatsu, ...
Journal of Neuroscience 25 (47), 10857-10862, 2005
2702005
Glucose hypometabolism and neuropathological correlates in brains of dementia with Lewy bodies
M Higuchi, M Tashiro, H Arai, N Okamura, S Hara, S Higuchi, M Itoh, ...
Experimental neurology 162 (2), 247-256, 2000
2522000
In vivo evaluation of a novel tau imaging tracer for Alzheimer’s disease
VL Villemagne, S Furumoto, MT Fodero-Tavoletti, RS Mulligan, J Hodges, ...
European journal of nuclear medicine and molecular imaging 41, 816-826, 2014
2122014
Cerebrospinal fluid clearance in Alzheimer disease measured with dynamic PET
MJ de Leon, Y Li, N Okamura, WH Tsui, LA Saint-Louis, L Glodzik, ...
Journal of Nuclear Medicine 58 (9), 1471-1476, 2017
2112017
Tau PET imaging in Alzheimer’s disease
N Okamura, R Harada, S Furumoto, H Arai, K Yanai, Y Kudo
Current neurology and neuroscience reports 14, 1-7, 2014
1932014
The development and validation of tau PET tracers: current status and future directions
N Okamura, R Harada, A Ishiki, A Kikuchi, T Nakamura, Y Kudo
Clinical and translational imaging 6, 305-316, 2018
1802018
Histamine H1 receptors in patients with Alzheimer’s disease assessed by positron emission tomography
M Higuchi, K Yanai, N Okamura, K Meguro, H Arai, M Itoh, R Iwata, T Ido, ...
Neuroscience 99 (4), 721-729, 2000
1722000
Selective cognitive dysfunction in mice lacking histamine H1 and H2 receptors
H Dai, K Kaneko, H Kato, S Fujii, Y Jing, A Xu, E Sakurai, M Kato, ...
Neuroscience research 57 (2), 306-313, 2007
1612007
Correlations of 18F-THK5351 PET with postmortem burden of tau and astrogliosis in Alzheimer disease
R Harada, A Ishiki, H Kai, N Sato, K Furukawa, S Furumoto, T Tago, ...
Journal of nuclear medicine 59 (4), 671-674, 2018
1562018
CSF phosphorylated tau protein and mild cognitive impairment: a prospective study
H Arai, K Ishiguro, H Ohno, M Moriyama, N Itoh, N Okamura, T Matsui, ...
Experimental neurology 166 (1), 201-203, 2000
1562000
Combined Analysis of CSF Tau Levels and [123I]Iodoamphetamine SPECT in Mild Cognitive Impairment: Implications for a Novel Predictor of Alzheimer’s Disease
N Okamura, H Arai, M Maruyama, M Higuchi, T Matsui, H Tanji, T Seki, ...
American Journal of Psychiatry 159 (3), 474-476, 2002
1542002
Functional neuroimaging of cognition impaired by a classical antihistamine, d-chlorpheniramine
N Okamura, K Yanai, M Higuchi, J Sakai, R Iwata, T Ido, H Sasaki, ...
British Journal of Pharmacology 129 (1), 115, 2000
1542000
In vivo measurement of vesicular monoamine transporter type 2 density in Parkinson disease with 18F-AV-133
N Okamura, VL Villemagne, J Drago, S Pejoska, RK Dhamija, ...
Journal of Nuclear Medicine 51 (2), 223-228, 2010
1512010
系统目前无法执行此操作,请稍后再试。
文章 1–20